Aramco Ventures | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,978 results for “Aramco Ventures”

B7-H3(Radiopharm Ventures)

UCH-L1 (Columbia Technology Ventures)

histone acetyltransferase activators (Columbia University/Columbia Technology Ventures)

PIP2 stimulating compounds

Somatropin biosimilar(Union Square Ventures LLC)

mesenchymal stem cells,Mayo Clinic Ventures

MAPK signaling pathway inhibitors (Columbia University/Columbia Technology Ventures)

Vesicular monoamine transporter 2 antagonists (Columbia Technology Ventures/Columbia University)

Investigational

Aramchol

Manufacturer: Galmed Pharmaceuticals Ltd.

Conditions: Liver Disease, GI Cancers

C₄₄H₇₉NO₅

RE Venture I

Page 1 of 4